Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer activity of an anti-thymidine kinase monoclonal antibody

Anti-cancer activity of an anti-thymidine kinase monoclonal antibody

US Patent 7837998 · Granted Nov 23, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of car and bite technology coupled with an SCFV from an antibody against hum2024
Transgenic macrophages, chimeric antigen receptors, and associated methods2024
Macrophage CAR (MOTO-CAR) in immunotherapy2022
Use of car and bite technology coupled with an SCFV from an antibody against hum2021
Transgenic macrophages, chimeric antigen receptors, and associated methods2021
Use of car and bite technology coupled with an ScFv from an antibody against hum2020
Use of car and bite technology coupled with an SCFV from an antibody against hum2020
Use of car and bite technology coupled with an scFv from an antibody against hum2019
Transgenic macrophages, chimeric antigen receptors, and associated methods2019
Compositions and methods for cancer management using antibodies binding to nucle2016
Monoclonal antibodies to human thymidine kinase to treat cancer2013
Anti-viral activity of an anti-thymidine kinase monoclonal antibody2007